Zevra Therapeutics, Inc. (ZVRA) Ownership

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$8.73
Day's range
$9.12

Zevra Therapeutics Inc Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
BLACKROCK, INC. 05/13/2026 4.46 M $41.53 M   -1.12% 7.63%
WOODLINE PARTNERS LP 05/15/2026 3.45 M $32.16 M   0.00% 5.91%
FMR LLC 05/15/2026 3.21 M $29.93 M   34.19% 5.50%
NANTAHALA CAPITAL MANAGEMENT, LLC 05/15/2026 2.52 M $23.50 M   42.33% 4.32%
VANGUARD CAPITAL MANAGEMENT LLC 05/15/2026 2.47 M $23.01 M   100.00% 4.23%
CAPTION MANAGEMENT, LLC 05/15/2026 2.00 M $18.67 M   81.87% 3.43%
STATE STREET CORP 05/15/2026 1.56 M $14.55 M   5.30% 2.67%
GEODE CAPITAL MANAGEMENT, LLC 05/15/2026 1.37 M $12.79 M   2.25% 2.35%
AIGH CAPITAL MANAGEMENT LLC 04/30/2026 1.20 M $11.18 M   100.00% 2.05%
MORGAN STANLEY 05/15/2026 1.19 M $11.11 M   2.97% 2.04%
LEGAL & GENERAL GROUP PLC 05/08/2026 1.16 M $10.84 M   5.93% 1.99%
POINT72 ASSET MANAGEMENT, L.P. 05/15/2026 1.16 M $10.78 M   100.00% 1.98%
ROYCE & ASSOCIATES LP 05/12/2026 988.67 K $9.21 M   14.19% 1.69%
683 CAPITAL MANAGEMENT, LLC 05/15/2026 975.00 K $9.09 M   7.73% 1.67%
D. E. SHAW & CO., INC. 05/15/2026 846.46 K $7.89 M   -2.00% 1.45%
QUBE RESEARCH & TECHNOLOGIES LTD 05/15/2026 842.32 K $7.85 M   136.45% 1.44%
KINGDON CAPITAL MANAGEMENT, L.L.C. 05/15/2026 775.00 K $7.22 M   32.46% 1.33%
GOLDMAN SACHS GROUP INC 05/15/2026 743.12 K $6.93 M   26.23% 1.27%
RETIREMENT PLANNING CO OF NEW ENGLAND, INC. 05/08/2026 651.15 K $6.07 M   -1.78% 1.11%
CITADEL ADVISORS LLC 05/15/2026 626.70 K $5.84 M   -25.65% 1.07%
MILLENNIUM MANAGEMENT LLC 05/15/2026 590.27 K $5.50 M   -47.96% 1.01%
DIMENSIONAL FUND ADVISORS LP 05/07/2026 554.80 K $5.17 M   259.17% 0.95%
SCHRODER INVESTMENT MANAGEMENT GROUP 05/14/2026 506.03 K $4.44 M   0.00% 0.87%
STONEPINE CAPITAL MANAGEMENT, LLC 05/14/2026 480.00 K $4.47 M   -15.65% 0.82%
05/08/2026 466.30 K $4.35 M   100.00% 0.80%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 05/15/2026 452.80 K $4.22 M   129.61% 0.78%
TUDOR INVESTMENT CORP ET AL 05/15/2026 443.11 K $4.13 M   -35.98% 0.76%
MARSHALL WACE, LLP 05/15/2026 439.95 K $4.10 M   -34.31% 0.75%
NORTHERN TRUST CORP 05/14/2026 436.95 K $4.07 M   4.50% 0.75%
UBS GROUP AG 05/05/2026 422.05 K $3.93 M   47.83% 0.72%
STRATOS WEALTH PARTNERS, LTD. 04/28/2026 408.00 K $3.80 M   -0.24% 0.70%
VANGUARD FIDUCIARY TRUST CO 05/08/2026 395.88 K $3.69 M   100.00% 0.68%
JPMORGAN CHASE & CO 05/13/2026 378.93 K $3.33 M   -8.08% 0.65%
MYSTIC ASSET MANAGEMENT, INC. 05/08/2026 361.28 K $3.37 M   4.26% 0.62%
FLPUTNAM INVESTMENT MANAGEMENT CO 05/05/2026 350.50 K $3.27 M   100.00% 0.60%
PROPEL BIO MANAGEMENT, LLC 05/14/2026 282.42 K $2.64 M   343.47% 0.48%
CAPTION MANAGEMENT, LLC 05/15/2026 255.24 K $2.38 M   -52.74% 0.44%
CITADEL ADVISORS LLC 05/15/2026 243.40 K $2.27 M   54.83% 0.42%
JANNEY MONTGOMERY SCOTT LLC 04/22/2026 236.83 K $2.21 M   16.73% 0.41%
JANE STREET GROUP, LLC 05/12/2026 221.06 K $2.06 M   -60.80% 0.38%
ADAGE CAPITAL PARTNERS GP, L.L.C. 05/15/2026 200.00 K $1.86 M   -27.27% 0.34%
NUVEEN, LLC 04/30/2026 192.59 K $1.79 M   34.55% 0.33%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 05/15/2026 186.58 K $1.74 M   -36.34% 0.32%
SQUAREPOINT OPS LLC 05/15/2026 182.86 K $1.70 M   -42.33% 0.31%
JANE STREET GROUP, LLC 05/12/2026 178.70 K $1.67 M   274.63% 0.31%
HENNION & WALSH ASSET MANAGEMENT, INC. 05/13/2026 177.16 K $1.65 M   26.92% 0.30%
KOVACK ADVISORS, INC. 05/13/2026 175.23 K $1.65 M   -0.06% 0.30%
BANK OF NEW YORK MELLON CORP 05/05/2026 172.43 K $1.61 M   -0.99% 0.30%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 05/15/2026 161.98 K $1.51 M   -10.32% 0.28%
PHOCAS FINANCIAL CORP. 05/01/2026 159.42 K $1.49 M   100.00% 0.27%

Zevra Therapeutics Inc institutional Ownership - FAQ's

During the previous two years, 179 institutional investors and hedge funds held shares of Zevra Therapeutics Inc. The most heavily invested institutionals were:

Retirement Planning Co of New England, Inc.: 634,410

Swedbank AB: 439,410

Hennion & Walsh Asset Management, Inc.: 383,706

FLPUTNAM INVESTMENT MANAGEMENT CO: 348,824

Phocas Financial Corp.: 295,907

Janney Montgomery Scott LLC: 272,194

70.74% of Zevra Therapeutics Inc stock is owned by institutional investors.

Institutional investors have bought a total of 46.13 M shares in the last 24 months. This purchase volume represents approximately $420.71 M in transactions.